Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Cleary, Michael L

Class:Id	Person:5621772
_displayName	Cleary, Michael L
_timestamp	2014-09-03 21:27:25
created	[InstanceEdit:5621730] May, Bruce, 2014-09-03
firstname	Michael L
initial	ML
surname	Cleary
(author)	[LiteratureReference:5621719] MicroRNA programs in normal and aberrant stem and progenitor cells [LiteratureReference:6809750] Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase [LiteratureReference:9036519] A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription [LiteratureReference:9687721] Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy [LiteratureReference:9818652] Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties [LiteratureReference:9818935] The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis [LiteratureReference:9818955] Menin critically links MLL proteins with LEDGF on cancer-associated target genes [LiteratureReference:9821230] Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
[Change default viewing format]

No pathways have been reviewed or authored by Cleary, Michael L (5621772)